Prevalence and prognosis of high-risk myocardial infarction patient candidates to extended antiplatelet therapy.

Marrugat de la Iglesia, Jaume; Elosua Llanos, Roberto; Sayols, Sergi; Dégano, Irene R.

doi:http://dx.doi.org/10.1016/j.rec.2015.12.022

Prevalence and prognosis of high-risk myocardial infarction patient candidates to extended antiplatelet therapy.

Citation

Marrugat J, Elosua R, Grau M, Sayols-Baixeras S, Dégano IR. Prevalence and prognosis of high-risk myocardial infarction patient candidates to extended antiplatelet therapy. Rev Esp Cardiol (Engl Ed). 2016 May;69(5):480-7. doi: 10.1016/j.rec.2015.12.022

Abstract

INTRODUCTION AND OBJECTIVES: Secondary prevention in myocardial infarction patients is paramount to prevent recurrences. Dual antiplatelet therapy has been shown to reduce the risk of subsequent events up to 1 year and beyond in the PEGASUS-TIMI 54 trial. This study aimed to estimate the annual number of myocardial infarction patients with PEGASUS characteristics in Spain and to analyze short- and long-term outcomes in these patients. METHODS: The number of myocardial infarction patients was estimated assuming a Poisson distribution. Myocardial infarction incidence and mortality rates obtained from population registries (IBERICA and REGICOR) were properly adjusted. The proportion of myocardial infarction patients with PEGASUS characteristics was estimated with a REGICOR cohort of consecutive patients from 2003-2009 (n=1391). This cohort follow-up was used to compare the occurrence of reinfarction and death at 1 year and at the end of the follow-up (4.7 years) in patients with and without PEGASUS characteristics by Cox regression. RESULTS: The estimated annual number of stable myocardial infarction patients aged ≥ 50 years and without bleeding events was 41 311. Of these, 22 493 had at least 1 PEGASUS characteristic (diabetes, previous myocardial infarction, or chronic kidney disease). At 4.7 years of follow-up, having any PEGASUS characteristic or age ≥ 65 years was associated with a higher risk of cardiovascular and all-cause death in adjusted analyses (hazard ratio=3.44 and 2.21, 95% confidence interval, 1.22-9.74 and 1.11-4.42, respectively). CONCLUSIONS: In Spain, more than 50% of the stable myocardial infarction patients aged ≥ 50 years are estimated to have at least 1 PEGASUS characteristic, which substantially increases the long-term risk of cardiovascular and all-cause death.